AAP Issues Updated Guidance on Palivizumab Prophylaxis for RSV Infection

被引：0

|

作者：

Lambert, Mara

机构：

来源：

AMERICAN FAMILY PHYSICIAN | 2014年 / 90卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

下载

收藏

页码：867 / 868

页数：2

相关论文

共 50 条

[41] A High Titer Anti RSV Polyclonal Antibody (RI-002) Prevents Infection with Palivizumab Resistant (PR) RSV in Cotton Rats and Achieves Greater Neutralizing RSV Activity As Compared to Palivizumab
Mond, James J.
Gilbert, Brian
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB165 - AB165
[42] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection
Scholz, H
ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122
[43] Prophylaxis protects infants with congenital heart disease from severe forms of RSV infection: an Italian observational retrospective study Palivizumab prophylaxis in children with congenital heart disease
Ratti, Chiara
della Greca, Anna
Bertoncelli, Deborah
Rubini, Monica
Tchana, Bertrand
ITALIAN JOURNAL OF PEDIATRICS, 2023, 49 (01)
[44] Emotional and time costs of respiratory syncytial virus prophylaxis: Comparing palivizumab to RSV-IG
Robbins, JM
Tilford, JM
Gillaspy, SR
Simpson, DD
Wheeler, JG
Shaw, JL
Jacobs, RF
PEDIATRIC RESEARCH, 2000, 47 (04) : 221A - 221A
[45] An outpatient program for administration of palivizumab prophylaxis for respiratory syncitial virus (RSV) in a subacute pediatric hospital
Gonzalez, F
Ballard, D
Hirsch, D
PEDIATRIC RESEARCH, 2002, 51 (04) : 218A - 218A
[46] AAP issues recommendations on infection control in physicians' offices
Hellekson, K
AMERICAN FAMILY PHYSICIAN, 2001, 63 (04) : 787 - 789
[47] Infant RSV prophylaxis, RSV infection, and nasopharyngeal microbiota at age six years
Man, Wing Ho
Scheltema, Nienke
Van Houten, Marlies
Nibbelke, Elisabeth
Achten, Niek
Arp, Kayleigh
Sanders, Elisabeth
Bont, Louis
Bogaert, Debby
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[48] Updated guidance on antibiotic prophylaxis against infective endocarditis
British Dental Journal, 2024, 237 (9) : 693 - 693
[49] COST-EFFECTIVENESS ANALYSIS OF PALIVIZUMAB AS A PROPHYLAXIS FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN HIGH-RISK LATE PRETERM INFANTS IN THE NETHERLANDS
Langenfeld, M. K.
Visser, S.
VALUE IN HEALTH, 2013, 16 (07) : A372 - A372
[50] Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection (vol 57, pg 259, 2000)
Robinson, RF
Nahata, MC
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2000, 57 (07) : 699 - 699

← 1 2 3 4 5 →